Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies
17. Oktober 2024 05:20 ET
|
IKTOS
Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies Paris (France), 17 October, 2024 – Iktos, a leader in...
Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery
08. Juli 2024 03:00 ET
|
IKTOS
PRESS RELEASE Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery Synsight provides Iktos with an...
Italfarmaco partners with Iktos on artificial intelligence to speed drug discovery breakthroughs for patients
18. Juni 2024 03:00 ET
|
IKTOS
PRESS RELEASE Italfarmaco partners with Iktos on artificial intelligence to speed drug discovery breakthroughs for patients Combines AI to increase the potential of novel histone deacetylase (HDAC)...
Iktos announces the appointment of Roman Fleck as Chairman of the Board
02. Mai 2024 02:45 ET
|
IKTOS
Paris (France), 2nd May 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the appointment of Roman Fleck as Chairman of the Board. Yann Gaston-Mathé steps...
Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji
14. Februar 2024 03:00 ET
|
IKTOS
Paris (France) and Tokyo (Japan), February 14, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the opening of Iktos K.K., its new subsidiary in Japan....
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
25. Januar 2024 06:30 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare...
PR : Iktos and Nerviano Medical Sciences S.r.l Announce Collaboration in Artificial Intelligence for New Drug Discovery
08. Januar 2024 02:00 ET
|
ULYSSE COMMUNICATION
Iktos and Nerviano Medical Sciences S.r.l Announce Collaboration in Artificial Intelligence for New Drug Discovery Paris, France, 8 January, 2023 – Iktos, a company specialized in Artificial...
CENTOGENE Announces Expansion of Data Access and Collaboration Agreement With Pfizer
17. März 2022 06:30 ET
|
Centogene NV
In November 2019, CENTOGENE first announced the signing of a data access and collaboration agreement to discover and validate novel genetic and biochemical targets for the potential development of new...
LAVA Therapeutics and The Antibody Society Present Emerging Cancer Therapies Virtual Symposium
11. November 2021 10:08 ET
|
LAVA Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA and FRAMINGHAM, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company, today announced that...
LAVA Therapeutics Announces Participation at Upcoming Scientific Conferences
02. November 2021 07:00 ET
|
Lava Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA, Nov. 02, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company focused on developing its proprietary...